WHO adds first mpox vaccine to prequalification list
The decision is expected to facilitate timely access to Bavarian Nordic’s Imvanex
Read More
Tag: mpox
McMaster drug trial receives more than $6m to test smallpox vaccine against mpox
Children accounted for the majority of mpox cases and deaths in the DRC since June 2023
Read More
NIHR reveals phase 1/2 trial to evaluate an investigational vaccine for mpox in the UK
More than 3,700 cases of mpox have been identified in the UK since May 2022
Read More
JCVI advises UK government on gonorrhoea and mpox vaccinations
Both programmes will be offered to those most at risk of developing STIs
Read More
- Transgene completes randomisation in phase 2 trial of tg4050
- Bayer wins MHRA approval for Kerendia in heart failure
- Oxford BioTherapeutics signs collaboration with Bristol Myers Squibb
- Kainova expands DT 7012 trial into Europe
- Amgen reports positive phase 3 results for subcutaneous TEPEZZA in thyroid eye disease
